Suppliers / Jiangsu Hainekon Biotechnology

Jiangsu Hainekon Biotechnology

China Updated 9 July 2026

Jiangsu Hainekon Biotechnology is an API manufacturer based in China. It holds one active US drug master file.

1
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Molecule Regulators Docs
Icosapent Ethyl US FDA 1

Also appears on these molecule pages

Icosapent Ethyl API

Questions about Jiangsu Hainekon Biotechnology

Does Jiangsu Hainekon Biotechnology hold a US DMF or a CEP?
Jiangsu Hainekon Biotechnology holds 1 active US drug master file. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
What does Jiangsu Hainekon Biotechnology make?
1 molecule is on record against Jiangsu Hainekon Biotechnology, including Icosapent Ethyl. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Jiangsu Hainekon Biotechnology comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Chunghwa Chemical Synthesis & Biotech shares 1 molecule Sichuan Gowell Pharmaceutical shares 1 molecule KinOmega Biopharm shares 1 molecule Finorga shares 1 molecule Kd Pharma Bexbach shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability